Home › Myoclonic Epilepsies
Myoclonic Epilepsies clinical trials recruiting in the U.S.
7 studies for Myoclonic Epilepsies are recruiting participants at sites across the United States.
Cities with the most studies
By state
Recently updated studies
A Fully Remote Feasibility Trial of Phenylbutyrate for SLC6A1-Related Disorders
RecruitingPhase 2
Ages 2 to 60 · All sexes · Updated Sep 29, 2026 · NCT07847918A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
RecruitingPhase 1/2
6 Months – 17 Years · All sexes · Updated Sep 22, 2026 · NCT05419492A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
RecruitingPhase 3
Ages 2 and older · All sexes · Updated Sep 15, 2026 · NCT04462770ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome
RecruitingPhase 1/2
Ages 2 to 12 · All sexes · Updated Sep 3, 2026 · NCT07531745The FINTEPLA as an Anti-SUDEP Therapy in Dravet Syndrome Project
RecruitingPhase 4
Ages 16 and older · All sexes · Updated Jul 15, 2026 · NCT07112365Assessment of Safety of the Use of Fenfluramine in Children With Dravet Syndrome Under 24 Months of Age
RecruitingPhase 4
12 Months – 24 Months · All sexes · Updated May 15, 2026 · NCT06598449GABA Biomarkers in Dravet Syndrome
RecruitingObservational studyHealthy volunteers welcome
Up to age 18 · All sexes · Updated Dec 14, 2022 · NCT05651204From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.